NEWS

• December 16, 2024 Notice of Change in Executive Structure This is to inform you of the change in the executive structure.
• October 10, 2024 EP-PharmaLine is a proud recipient of Contact Center Awards 2024 "Jury‘s Special Award". EP-PharmaLine received the Jury‘s Special Award at the Contact Center Awards 2024, hosted by Rick Telecom Co., Ltd. and the editorial department of Call Center Japan.
  Awards
• July 1, 2024 Notice of Fukuoka Office Relocation As of July 1, 2024, EP-PharmaLine's Fukuoka office has relocated to the following address :
  Taihaku Center Building 6F, 2-19-24 Hakata-ekimae Hakata-ku, Fukuoka City, Fukuoka 812-0011, Japan Profile
• May 14, 2024 Announcement of Feature in Pharma Tech Outlook "Vendor Viewpoints" EP-PharmaLine has been featured in the "Vendor Viewpoint" section of Pharma Tech Outlook.
  Awards
  【Vendor Viewpoints: The Strength of EP-PharmaLine in Adapting to Japan’s medical Industry】 https://pharma-consulting-apac.pharmatechoutlook.com/vp/-ep-pharmaline/the_strength_of_ep-pharmaline_in_adapting_to_japan's_unique_medical_industry/
• March 21, 2024 Certified "KENKO Investment for Health Outstanding Organizations Recognition Program 2024"
• October 2, 2023 EP-PharmaLine is a proud recipient of Contact Center Awards 2023 "Jury‘s Special Award". EP-PharmaLine received the Jury‘s Special Award at the Contact Center Awards 2023, hosted by Rick Telecom Co., Ltd. and the editorial department of Call Center Japan.
  Awards
• August 1, 2023 EP-PharmaLine Named One of the Top Pharma Consulting Company in Japan 2023 EP-PharmaLine Company has been named one of the "Top Pharma Consulting Company in Japan 2023" by Pharma Tech Outlook APAC.
  The article provides the overview of EP-PharmaLine, its business initiatives and achievements.
  Awards
  EP-PharmaLine | Top Pharma Consulting Company in Japan-2023 (pharmatechoutlook.com)
• October 25,2022 Notice of Change in Parent Company This is to inform you of the change in the Parent Company.
• May 27,2021 Notice from EPS Holdings Notice Regarding Agreement with SUZUKEN Co., Ltd. for Equity Participation in EP-PharmaLine
• June 1,2020 Notice of Split of CMR Business and Succession of Business by EP-Force Co., Ltd. On June 1, 2020, EP-PharmaLine Co., Ltd. and EP-Force Co., Ltd. split off the CMR business of EP-PharmaLine Co., Ltd. and EP-Force Co., Ltd. took over the CMR business for the purpose of further business development
  COMPANY DATA　EP-Force Co., Ltd. (epforce.co.jp)
• May 14,2020 Introducing the COVID-19 Contact Center Services Launched contact center and mental health consultation center related to COVID-19
• May 12,2020 Notice of Company Split and Business Succession The CMR business of EP-PharmaLine Co., Ltd. was split off on June 1, 2020 and EP-Force Co., Ltd. took over the CMR business.
• April 15,2020 Notice Concerning Reorganization of Subsidiary of our company From June 1, 2020 (planned), the Company has decided to transfer EP-PharmaLine's MR outsourcing business to EP-Force through an absorption-type company split.